-
2023-508101-24-00
5
2019-08-01
Lymphoblastic lymphoma
-
2024-514556-32-00
5
2017-02-15
Adult critically ill patients with severe vitamin D deficiency
-
2024-512222-28-00
10
2015-06-02
Newly diagnosed with an intracranial or spinal ependymoma (all WHO gra
-
2025-521912-21-00
4
2026-01-26
Cardiovascular risk reduction in participants with elevated Lp(a)
-
2025-520775-81-00
5
2025-12-23
Short Bowel Syndrome
-
2024-520155-24-00
4
2025-10-16
Metastatic castration resistant prostate cancer (mCRPC)
-
2024-512720-11-00
5
2025-01-16
chronic venous ulcers (CVU)
-
2024-510730-40-00
5
2024-12-12
Hidradenitis Suppurativa
-
2023-509301-80-00
5
2024-11-04
Severe hypertriglyceridemia (SHTG)
-
2022-501457-37-00
5
2024-10-28
Myeloid Leukemia in Children with Down Syndrome
-
2023-508636-61-00
5
2024-10-24
Crohn’s Disease
-
2023-505655-43-00
7
2024-07-29
Metastatic neuroendocrine prostate cancer
-
2023-503594-38-00
1
2024-07-15
Select B-Cell malignancies.
-
2022-500571-32-00
4
2024-05-15
Early-Stage Unfavorable Classical Hodgkin Lymphoma
-
2022-502134-10-00
3
2024-05-15
Glioblastoma
-
2022-503040-41-00
4
2024-02-09
PSMA PET scan positive Castration-Resistant Prostate Cancer (CRPC)
-
2024-514458-61-01
4
2024-02-05
HER2+ early breast cancer
-
2023-503652-27-00
5
2023-10-06
Melanoma
-
2022-502188-39-00
4
2023-09-27
Dermatitis atopic
-
2022-502145-10-00
5
2023-06-06
Hormone Receptor (HR)-Positive, Human Epidermal Growth Factor Receptor
-
2022-501608-85-00
5
2023-05-09
Cardiovascular disease (atherosclerotic cardiovascular disease (ASCVD)
-
2023-504741-32-00
4
2022-11-30
Moderately to Severely Active Crohn's Disease
-
2024-514082-19-00
4
2022-11-04
Amyotrophic Lateral Sclerosis
-
2024-516438-36-00
4
2022-09-13
Patients with very low, low or intermediate risk myelodysplastic syndr